Skip to main content
Table of Contents
Print

Are embryo genetic tests relevant to autism for advanced parental age? 

Author: Hannah Smith, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

As more people delay starting families, interest in embryo genetic testing and autism is growing. Can today’s tests predict autism risk before implantation? The answer is no. Embryo genetic testing is highly effective for identifying certain genetic conditions, but it does not currently extend to detecting autism, even for those of advanced parental age. 

Tests such as PGT (pre-implantation genetic testing) are usually used to identify major chromosomal abnormalities, including those found through aneuploidy screening. These are particularly relevant for older parents, where the risk of chromosomal anomalies increases. However, when it comes to embryo genetic testing and autism, the connection remains limited. This is because autism often results from a combination of subtle genetic variations and environmental influences, well beyond what current testing can detect. 

What embryo genetic testing can (and cannot) tell you 

There are clear benefits to embryo genetic testing, but also important genetic screening limits to bear in mind: 

Detects major chromosomal conditions  

Aneuploidy screening can identify embryos with too many or too few chromosomes, helping to reduce the risk of miscarriage or recognised genetic disorders. However, it does not predict autism. 

Guides safer pregnancy choices 

While PGT provides reassurance in embryo selection, the scope of embryo genetic testing and autism is still limited. Most autism-related genetic variations cannot be identified at this stage. 

Visit providers like Autism Detect for personal consultations to understand how maternal health and sensory processing may influence your child’s development and how to support effective sensory regulation and comfort. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Advanced Parental Age.

Hannah Smith, MSc
Author

Hannah Smith is a clinical psychologist with a Master’s in Clinical Psychology and over three years of experience in behaviour therapy, special education, and inclusive practices. She specialises in Applied Behavior Analysis (ABA), Cognitive Behavioural Therapy (CBT), and inclusive education strategies. Hannah has worked extensively with children and adults with Autism Spectrum Disorder (ASD), ADHD, Down syndrome, and intellectual disabilities, delivering evidence-based interventions to support development, mental health, and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS
Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 

Categories